Connect with others who understand.

Sign up Log in
Resources
About MyMSTeam
Powered By
See answer
See answer

Treatments for Relapsing MS

Written by Kelly Crumrin
Updated on February 24, 2025

As of 2024, more than 20 different DMTs have been approved by the U.S. Food and Drug Administration (FDA) for treating relapsing MS. Research has proved that DMTs can reduce the frequency of clinical attacks (also called relapses, flare-ups, or exacerbations) and the development of new brain lesions and spinal cord damage. Some DMTs have also been shown to slow the accumulation of disability.

Overall, DMTs slow disease progression and might help keep relapsing MS stable. Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting multiple sclerosis (RRMS), and active secondary progressive MS (SPMS).

With so many treatment options, how can someone diagnosed with relapsing MS know which MS treatment will be best for them? For some people, how a DMT is taken and how often it is taken are important factors — especially considering DMTs are taken long term, usually for years. Some prefer a medication taken orally over one taken by injection or intravenous infusion. Others prefer a more convenient dosage schedule with medication taken only a few times a year. It can also help to know how different classes of DMTs work.

Each DMT has potential side effects, which may be mild or severe, common or very rare. Your doctor can help you weigh the possible benefits and risks of each option.

Read on to find out which DMTs are prescribed for relapsing forms of MS, how each is taken, and what may lead doctors to recommend one over another.

Weighing the Risks and Benefits of DMTs

All medications, even those sold over the counter, have potential side effects. Treatments for relapsing MS are no different, and each has possible risks.

Risks Vary Between Individuals

Some side effects are more common, and others are extremely rare. Risk-averse people may prefer to avoid DMTs with a potential for serious side effects, even if those side effects occur very rarely. Others may prefer to focus on which DMT will be most effective in modifying the course of their MS, even if they carry a low risk for severe adverse effects.

Some DMTs have contraindications — circumstances that raise the risk for serious side effects for people who have other health conditions in addition to MS. For instance:

  • Some DMTs, such as natalizumab, may not be recommended for people who test positive for antibodies of the John Cunningham (JC) virus.
  • Other DMTs, such as teriflunomide, may not be safe for people with liver dysfunction.

Your personal risk for developing serious side effects depends on many factors. Your doctor can help you understand your risk for side effects with any medication. If you have any other health problems or conditions, your doctor may avoid prescribing certain DMTs.

Active MS May Call for Different Treatment

Doctors may recommend DMTs based on many factors. One important factor is MS disease activity. An individual’s MS may be active or inactive. Active disease means having a clinical relapse or detecting new lesions on an MRI scan over a period of time, usually a year.

When your MS is active, you’re more likely to experience new damage to the central nervous system. Doctors may suggest different DMTs based on whether your MS is considered to be active or inactive.

List of Treatments for Relapsing MS

According to the Consortium of Multiple Sclerosis Centers (CMSC), a large organization of healthcare providers for those with MS, any approved DMT may be considered as the first treatment for someone diagnosed with a relapsing type of MS. The choice should be based on what is best for the individual. Your doctor will help you decide on the treatment that works best for your needs and symptoms.

The following DMTs have been approved by the FDA to treat relapsing forms of MS.

DMTs for Relapsing Forms of Multiple Sclerosis
Disease-modifying treatment How it’s taken Dosage schedule
Alemtuzumab (Lemtrada) IV infusion Five days in a row, then three days one year later
Cladribine (Mavenclad) Oral 10 pills in year one, 10 pills in year two
Dimethyl fumarate (Tecfidera) Oral Twice a day
Diroximel fumarate (Vumerity) Oral Twice a day
Fingolimod (Gilenya) Oral Once a day
Glatiramer acetate (Copaxone) Injection Daily or three times a week
Interferon beta-1a (Avonex) Injection Once a week
Interferon beta-1a (Rebif) Injection Three times a week
Interferon beta-1b (Betaseron) Injection Every other day
Interferon beta-1b (Extavia) Injection Every other day
Monomethyl fumarate (Bafiertam) Oral Twice a day
Natalizumab (Tysabri) IV infusion Monthly
Ocrelizumab (Ocrevus) IV infusion Every six months
Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)* Injection Twice a year
Ofatumumab (Kesimpta) Injection Monthly
Ozanimod (Zeposia) Oral Once a day
Peginterferon beta-1a (Plegridy) Injection Every two weeks
Ponesimod (Ponvory) Oral Once a day
Siponimod (Mayzent) Oral Once a day
Teriflunomide (Aubagio) Oral Once a day
Ublituximab (Briumvi) IV infusion 2.5-hour IV infusion every six months

Based on information sourced from “Treatment for MS” provided by MS Focus at https://msfocus.org/Get-Educated/Treatment-for-MS.aspx

*Based on information sourced from “FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis Society at https://www.nationalmssociety.org/news-and-magazine/news/fda-approves-ocrevus-zunovo

Changing DMTs

Remember that no DMT can cure or completely stop MS. According to Cleveland Clinic, switching treatments may be considered when:

  • Your MS isn’t responding adequately to treatment. This is a subjective measurement, but signs may include a relapse, new or worsening lesions, or worsening results during a neurologic exam within a year of starting therapy.
  • You have significant side effects from the first therapy, or a new symptom or contraindication raises the risk for side effects.
  • You no longer have access to the first DMT.
  • You have trouble taking the first DMT or can’t tolerate its side effects.

If you’re switching drugs because the DMT you’ve been taking has been ineffective, your doctor will likely recommend a drug that works in a different way.

If you believe you’re having a relapse, communicate with your healthcare provider. Be sure to tell them how your relapse feels. It can sometimes be difficult to know whether you’re experiencing a clinical MS relapse or MS symptoms made worse by stress or infection.

How Different DMTs Work

DMTs have different mechanisms of action, which means they work in different ways. Most DMTs modify different aspects of the immune system to prevent autoimmune attacks on the myelin that sheathes nerve fibers. Understanding how DMTs work can provide insight into why your doctor recommends a medication. For instance, if you’re switching drugs because the DMT you’ve been taking hasn’t helped, your doctor will likely recommend a drug that works in a different way.

Here’s a breakdown of DMTs for relapsing MS by mechanism of action.

How Different DMTs Work in Relapsing-Remitting Multiple Sclerosis
Disease-modifying treatments Believed mechanism of action
Alemtuzumab (Lemtrada) Alemtuzumab lowers the number of circulating B cells and T cells.

Cladribine (Mavenclad)a

Cladribine reduces the number of white blood cells, especially B cells.

Fingolimod (Gilenya)b
Siponimod (Mayzent)
Ponesimod (Ponvory)
Ozanimod (Zeposia)

These drugs block white blood cells from leaving lymph nodes, reducing their numbers in the central nervous system.

Glatiramer acetate (Copaxone)

Glatiramer acetate encourages and activates helper T cells and regulatory T cells. It supports the growth and development of neurons (brain cells). It may also target antigen-presenting cells involved in autoimmune attacks.

Interferon beta-1a (Avonex)
Interferon beta-1a (Rebif)
Peginterferon beta-1a (Plegridy)

Beta-interferons inhibit T-cell numbers and activation. They encourage the activity of regulatory T cells and the death of T cells involved in autoimmunity. They help prevent the migration of white blood cells across the blood-brain barrier.

Interferon beta-1b (Betaseron)
Interferon beta-1b (Extavia)

These work similarly to interferon beta-1a, above.

Monomethyl fumarate (Bafiertam)c
Dimethyl fumarate (Tecfidera)
Diroximel fumarate (Vumerity)

These reduce inflammation involved in MS.
Natalizumab (Tysabri) Natalizumab prevents white blood cells from migrating into inflamed tissues.

Ocrelizumab (Ocrevus)
Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)d
Ofatumumab (Kesimpta)

These drugs encourage the destruction of B cells involved in MS attacks.

Teriflunomide (Aubagio)

Teriflunomide reduces the number of activated white blood cells in the central nervous system.
Ublituximab (Briumvi) A monoclonal antibody designed to bind B cells — a type of white blood cell — and decrease their numbers.

Based on information sourced from “CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies in Multiple Sclerosis” at https://cmscscholar.org/cmsc-practical-guidelines-for-the-selection-of-disease-modifying-therapies-in-ms/

aBased on information sourced from “The Story of Cladribine Reaches Its Climax” provided by Nature at www.nature.com/articles/d42859-018-00029-1

bBased on information sourced from “Vumerity Oral Capsules Approved by the FDA for Adults with Relapsing Forms of MS, Including Active SPMS ” provided by the Multiple Sclerosis Association of America at https://mymsaa.org/news/vumerity-approved-fda-adults-relapsing-ms-including-spms/

cBased on information sourced from Bafiertam at www.bafiertam.com

dBased on information sourced from “FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis Society at https://www.nationalmssociety.org/news-and-magazine/news/fda-approves-ocrevus-zunovo

For people living with active relapsing MS, your healthcare team may use MRI scans and biomarker tests to help you make the choice about which DMT to try. Sometimes, the only way to know whether a DMT will be effective for you is to begin taking it. Many people with relapsing MS find it necessary to switch to a different DMT over the course of their treatment. If you’re curious about what treatment options for relapsing MS are available for you, talk to your neurologist.

Talk With Others Who Understand

On MyMSTeam, the social network for people with multiple sclerosis and their loved ones, more than 218,000 members come together to ask questions, give advice, and share their stories with those who understand life with MS.

Do you still have questions about disease-modifying treatments for relapsing MS? Share them in the comments below, or start a conversation with others on your Activities page.

References
  1. The Benefits and Considerations for Using Disease-Modifying Therapies (DMTS) for Multiple Sclerosis — National Multiple Sclerosis Society
  2. Multiple Sclerosis — National Institute of Neurological Disorders and Stroke
  3. Effect of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Multiple Sclerosis: A Retrospective Observational Study — Multiple Sclerosis and Related Disorders
  4. Early Use of High-Efficacy Disease‑Modifying Therapies Makes the Difference in People With Multiple Sclerosis: An Expert Opinion — Journal of Neurology
  5. Impact of Disease-Modifying Therapies on MRI and Neurocognitive Outcomes in Relapsing-Remitting Multiple Sclerosis: A Protocol for a Systematic Review and Network Meta-Analysis — BMJ Open
  6. Disease-Modifying Therapy Discontinuation in Multiple Sclerosis — Cleveland Clinic
  7. Contraindication — MedlinePlus
  8. CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies in Multiple Sclerosis — CMSC Scholar
  9. JC Virus and PML — Multiple Sclerosis Trust
  10. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review — CNS Drugs
  11. New Multiple Sclerosis Phenotypic Classification — European Neurology
  12. Mellen Center Approaches: Initial Treatment of Relapsing Forms of MS — Cleveland Clinic
  13. Treatment for MS — Multiple Sclerosis Foundation
  14. FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus — National Multiple Sclerosis Society
  15. Disease Modifying Therapies — Multiple Sclerosis Society
  16. The Evolution of Multiple Sclerosis Disease-Modifying Therapies: An Update for Pharmacists — American Journal of Health-System Pharmacy
  17. DMTs, Vaccines and MS: What Does This Mean for Your Immune System? — Multiple Sclerosis Australia
  18. Vumerity Oral Capsules Approved by the FDA for Adults With Relapsing Forms of MS, Including Active SPMS — Multiple Sclerosis Association of America
  19. The Story of Cladribine Reaches Its Climax — Nature Portfolio

Kiran Chaudhari, M.B.B.S., M.D., Ph.D. is a specialist in pharmacology and neuroscience and is passionate about drug and device safety and pharmacovigilance. Learn more about him here.
Kelly Crumrin is a senior editor at MyHealthTeam and leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

A MyMSTeam Member

I was on 2 different Interferon with bad results. First I became a diabetic with high numbers. Never was diabetic before so that was major! 3 weeks after I was fine. With the second RAGE was an… read more

All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
265,077 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
265,077 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use

Is Sol Medrol 1Gm Effective Treatment For Relapse Progressive Ms?

By A MyMSTeam Member 10 answers
View Answers

Thank you for subscribing!

Become a member to get even more